年报三大痛点被问询多家ST类公司“摘帽”

Core Viewpoint - The 2024 annual report disclosure for listed companies has concluded, with a focus on the authenticity and quality of financial statements under regulatory scrutiny, particularly for companies in the "ST family" [1] Group 1: Financial Performance and Reporting - Seven companies from the "ST family" have received inquiries regarding their 2024 annual reports, focusing on issues such as inflated revenue, ongoing viability, and conditions for delisting [1] - *ST Hengyu reported a turnaround in performance with revenues of 180 million yuan in 2024, following a negative revenue of 81.77 million yuan in 2023, which triggered delisting risk warnings [2] - *ST Jiawo faced inquiries due to a significant loss of 924 million yuan in 2024, requiring detailed explanations of production costs and revenue impacts [3] Group 2: Ongoing Viability and Risk Assessment - New delisting rules have raised the revenue threshold for loss-making companies from 100 million yuan to 300 million yuan, emphasizing the assessment of ongoing viability [4] - ST Tianbang received an audit report highlighting significant uncertainty regarding its ongoing viability, with a debt ratio of 72.58% and current liabilities exceeding current assets [4][5] - *ST Shandong Molong, which had negative net profits for six consecutive years, managed to eliminate the uncertainty regarding its ongoing viability in its 2024 report, leading to the removal of risk warnings [6][7] Group 3: Delisting and Risk Warning Procedures - The inquiry process for companies seeking to remove delisting risk warnings is stringent, with a focus on compliance with new regulations [8] - *ST XinNing successfully demonstrated the elimination of conditions that warranted delisting risk warnings, leading to its stock resuming trading under a new name [8][9] - ST Bubugao also navigated the inquiry process successfully, receiving a standard audit opinion and subsequently removing its risk warnings [8][9]